PIPages
Labs

Matthew Bogyo

Stanford University, CA·Chemistry

Proteases are enzymes that cut other proteins. Many bacteria rely on proteases that are active only during infection, which makes these enzymes useful markers of disease.

Fields

Chemistry

Microbiology & Immunology

Biomedical Engineering

Topics

chemical biology

activity-based probes

covalent probes

Grants
2 known grants, through Jul 2029

What they work on

  1. Design and synthesize covalent peptide probes with electrophilic warheads that permanently and selectively bind BbHtrA, a Lyme disease bacterial protease that stays active at all infection stages.
  2. Attach these probes to a quasi-freestanding epitaxial graphene biosensor and test whether it rapidly detects Borrelia burgdorferi in small samples of patient blood and urine and in test synovial fluid.
  3. Develop a covalent active-site probe that targets DD-CPases, cell-wall enzymes found only in bacteria, in the five main bacterial causes of otitis media.
  4. Show in culture that a single probe carrying a fluorescent phototherapy dye can both image and, with light exposure, kill all five common ear-infection bacteria.
  5. Use validated probes in a mouse model of otitis media to confirm that the probes light up infected ears and that light treatment clears each of the five bacteria.

More about the research

Both of this lab's projects design covalent chemical probes, small molecules that bind permanently to a protease's active site, to detect bacteria. Covalent binding lets a probe tell an active infection apart from leftover traces of a past one. One project uses such probes for a Lyme disease test. The other uses them to see and kill the bacteria that cause ear infections in children.

Why it matters

Lyme disease often goes undiagnosed until it causes arthritis, heart, or nerve problems. A simple, inexpensive test for active Borrelia infection could allow earlier antibiotic treatment. For children with middle-ear infections, a probe that both confirms a bacterial cause and kills the bacteria with light could reduce unnecessary antibiotic use, which drives drug-resistant bacteria. The same approach could extend to other diseases with protease markers.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Chemical probes for imaging and treatment of otitis media

NIH · Aug 2025 – Jul 2029

Protease sensor for rapid and sensitive detection of Borrelia infections

NIH · Aug 2025 – Jul 2027

Closest labs

Karen Cyndari

University of Iowa, IA·Microbiology & Immunology·Early-career

Measure whether Borrelia burgdorferi infection breaks down the tight-junction barrier formed by resident synovial macrophages, using infected human synovial explants imaged by confocal microscopy and histomorphometry.

Timothy Casselli

University of South Alabama, AL·Microbiology & Immunology

Determine whether the blood-cerebrospinal fluid barrier, the cell layer separating blood from the fluid around the brain, is where Borrelia burgdorferi and immune cells enter the central nervous system in infected mice.

Stephen Boppart

University of Illinois Urbana-Champaign, IL·Biomedical Engineering

Test whether adding optical coherence tomography, a light-based imaging method that sees behind the eardrum, to standard pneumatic otoscopy improves diagnostic accuracy and reduces antibiotic prescriptions in children presenting to primary care with ear pain or suspected otitis media.

The school

Stanford University: 87 labs on PI Pages, $1.6B a year on research, 739 research doctorates a year.

More about Stanford University

Reach out

A start for your email. Fill in the brackets.